Theravance names Michael Aguiar CEO
This article was originally published in Scrip
San Francisco, California-based Theravance Inc has appointed Michael W Aguiar as president and chief executive officer of the company effective 15 August, and as a member of its board of directors effective immediately. Mr Aguiar will replace Rick E Winningham who has resigned as CEO of Theravance Inc. Mr Winningham will however remain chair of Theravance's board and transition to full time CEO of spin out unit Theravance Biopharma.
You may also be interested in...
It is time for In Vivo's 13th annual Deals of the Year contest. We've selected 15 nominees in three categories – Top Alliance, Top Financing and Top M&A – and you get to pick the winners.
Derived from Biomedtracker, the Deal-Making column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced in October 2020. Data provided by Biomedtracker.
An interactive look at recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.